BIOFLOW-III Austria Satellite Registry

NCT01667016 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 305

Last updated 2017-09-28

No results posted yet for this study

Summary

This registry is a clinical post-market evaluation of the Orsiro LESS in subjects requiring coronary revascularization with Drug Eluting Stents (DES).

Conditions

Sponsors & Collaborators

  • Biotronik Vertriebs-GmbH

    lead INDUSTRY

Principal Investigators

  • Thomas Neunteufl, Prof. Dr. · Universitaetsklinik fuer innere Medizin II, Vienna

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2014-06-30
Completion
2014-12-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01667016 on ClinicalTrials.gov